This Article Full Text Full Text (PDF) All Versions of this Article: 43/2/276    most recent 01.HYP.0000113628.94574.0fv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhang, X. Articles by Cao, Z. Search for Related Content PubMed PubMed Citation Articles by Zhang, X. Articles by Cao, Z. Related Collections ACE/Angiotension receptors Growth factors/cytokines Type 1 diabetes

(Hypertension. 2004;43:276.)
© 2004 American Heart Association, Inc.

Scientific Contributions

Retinal Expression of Vascular Endothelial Growth Factor Is Mediated by Angiotensin Type 1 and Type 2 Receptors

From The JDRF Danielle Alberti Memorial Centre for Diabetes Complications, Baker Heart Research Institute, Melbourne, Australia.

Correspondence to Dr Zemin Cao, The JDRF Danielle Alberti Memorial Centre for Diabetes Complications, Baker Medical Research Institute, P.O. Box 6492, St Kilda Road, Central Melbourne 8008, Victoria, Australia. E-mail zemin.cao{at}baker.edu.au

Angiotensin II is a known stimulus for the expression of vascular endothelial growth factor (VEGF). This action of angiotensin II is mediated by the angiotensin type 1 (AT1) receptor. However, the role of the angiotensin type 2 (AT2) receptor subtype in inducing VEGF expression has been controversial. The aim of the present study was to assess the effects of AT2 receptor blockade on VEGF expression in the retina, initially in experimental diabetic rats induced by injection of streptozotocin. The AT1 receptor antagonist, valsartan, or the AT2 receptor antagonists, PD123319, were administered to diabetic rats for 4 weeks. Increased gene and protein expressions of VEGF, as assessed by real-time reverse transcription-polymerase chain reaction and immunostaining, respectively, were observed in the retina in diabetic rats. Treatment with either valsartan or PD123319 attenuated retinal VEGF expression. To further explore the link between angiotensin receptor subtypes and VEGF expression, valsartan, or PD123319 were administered to rats that were infused with angiotensin II for 2 weeks. VEGF expression was also increased in the retina from angiotensin II infused rats, and this was attenuated by valsartan and PD123319. These findings suggest that VEGF expression is modulated by AT1 and AT2 receptors, thereby implicating angiotensin II receptor subtypes in retinal diseases such as diabetic retinopathy.

Key Words: angiotensin receptors • vascular endothelial growth factor • diabetes

This article has been cited by other articles:

				C. Clapp, S. Thebault, M. C. Jeziorski, and G. Martinez De La Escalera Peptide Hormone Regulation of Angiogenesis Physiol Rev, October 1, 2009; 89(4): 1177 - 1215. [Abstract] [Full Text] [PDF]

				E. I. Ager, J. Neo, and C. Christophi The renin-angiotensin system and malignancy Carcinogenesis, September 1, 2008; 29(9): 1675 - 1684. [Abstract] [Full Text] [PDF]

				P. Chen, A. M. Guo, P. A. Edwards, G. Trick, and A. G. Scicli Role of NADPH oxidase and ANG II in diabetes-induced retinal leukostasis Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1619 - R1629. [Abstract] [Full Text] [PDF]

				N. Nagai, K. Izumi-Nagai, Y. Oike, T. Koto, S. Satofuka, Y. Ozawa, K. Yamashiro, M. Inoue, K. Tsubota, K. Umezawa, et al. Suppression of Diabetes-Induced Retinal Inflammation by Blocking the Angiotensin II Type 1 Receptor or Its Downstream Nuclear Factor-{kappa}B Pathway Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4342 - 4350. [Abstract] [Full Text] [PDF]

				D. N. Muller and F. C. Luft Direct Renin Inhibition with Aliskiren in Hypertension and Target Organ Damage Clin. J. Am. Soc. Nephrol., March 1, 2006; 1(2): 221 - 228. [Abstract] [Full Text] [PDF]

				F. C. Sasso, D. Torella, O. Carbonara, G. M. Ellison, M. Torella, M. Scardone, C. Marra, R. Nasti, R. Marfella, D. Cozzolino, et al. Increased Vascular Endothelial Growth Factor Expression But Impaired Vascular Endothelial Growth Factor Receptor Signaling in the Myocardium of Type 2 Diabetic Patients With Chronic Coronary Heart Disease J. Am. Coll. Cardiol., September 6, 2005; 46(5): 827 - 834. [Abstract] [Full Text] [PDF]

				S. Bedard, B. Sicotte, J. St-Louis, and M. Brochu Modulation of body fluids and angiotensin II receptors in a rat model of intra-uterine growth restriction J. Physiol., February 1, 2005; 562(3): 937 - 950. [Abstract] [Full Text] [PDF]

				J. A. Phipps, E. L. Fletcher, and A. J. Vingrys Paired-Flash Identification of Rod and Cone Dysfunction in the Diabetic Rat Invest. Ophthalmol. Vis. Sci., December 1, 2004; 45(12): 4592 - 4600. [Abstract] [Full Text] [PDF]